Evidence map›Paper›PMID 26696417›Full record

ArticlePloS one2015

Change in Dengue and Japanese Encephalitis Seroprevalence Rates in Sri Lanka.

Chandima Jeewandara, Laksiri Gomes, S A Paranavitane, Mihiri Tantirimudalige, Sumedha Sandaruwan Panapitiya, Amitha Jayewardene, Samitha Fernando, R H Fernando, Shamini Prathapan, Graham S Ogg and 1 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 45 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Chandima JeewandaraCentre for Dengue Research, Department of Microbiology, Faculty of Medical Sciences, University of Sri Jayawardenapura, Nugegoda, Sri Lanka.
Laksiri GomesCentre for Dengue Research, Department of Microbiology, Faculty of Medical Sciences, University of Sri Jayawardenapura, Nugegoda, Sri Lanka.
S A ParanavitaneCentre for Dengue Research, Department of Microbiology, Faculty of Medical Sciences, University of Sri Jayawardenapura, Nugegoda, Sri Lanka.
Mihiri TantirimudaligeCentre for Dengue Research, Department of Microbiology, Faculty of Medical Sciences, University of Sri Jayawardenapura, Nugegoda, Sri Lanka.
Sumedha Sandaruwan PanapitiyaCentre for Dengue Research, Department of Microbiology, Faculty of Medical Sciences, University of Sri Jayawardenapura, Nugegoda, Sri Lanka.
Amitha JayewardeneDepartment of Family Medicine, Faculty of Medical Sciences, University of Sri Jayawardanapura, Nugegoda, Sri Lanka.
Samitha FernandoCentre for Dengue Research, Department of Microbiology, Faculty of Medical Sciences, University of Sri Jayawardenapura, Nugegoda, Sri Lanka.
R H FernandoCentre for Dengue Research, Department of Microbiology, Faculty of Medical Sciences, University of Sri Jayawardenapura, Nugegoda, Sri Lanka.
Shamini PrathapanCentre for Dengue Research, Department of Microbiology, Faculty of Medical Sciences, University of Sri Jayawardenapura, Nugegoda, Sri Lanka.
Graham S OggMRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, Oxford NIHR Biomedical Research Centre and University of Oxford, United Kingdom.
Gathsaurie Neelika MalavigeCentre for Dengue Research, Department of Microbiology, Faculty of Medical Sciences, University of Sri Jayawardenapura, Nugegoda, Sri Lanka.
University of Sri Jayewardenepura · LKChurchill Hospital · GB

Funding

Medical Research Council MC_UU_12010/5
6 · The paper itself

Abstract

backgroundSri Lanka has been affected by epidemics of dengue infections for many decades and the incidence and severity of dengue infections have been rising each year. Therefore, we investigated the age stratified seroprevalence of dengue infections in order to facilitate future dengue vaccine strategies. In addition, since the symptomatic dengue infections have increased during the past few decades, we also investigated the possible association with Japanese Encephalitis Virus (JEV) antibody seropositivity with symptomatic dengue in a community cohort in Sri Lanka.

methods1689 healthy individuals who were attending a primary health care facility were recruited. Dengue and JEV antibody status was determined in all individuals and JEV vaccination status was recorded.

results1152/1689 (68.2%) individuals were seropositive for dengue and only 133/1152 (11.5%) of them had been hospitalized to due to dengue. A significant and positive correlation was observed for dengue antibody seropositivity and age in children (Spearmans R = 0.84, p = 0.002) and in adults (Spearmans R = 0.96, p = 0.004). We observed a significant rise in the age stratified seroprevalence rates in children over a period of 12 years. For instance, in year 2003 the annual seroconversion rate was 1.5% per annum, which had risen to 3.79% per annum by 2014. We also found that both adults (p<0.001) and in children (p = 0.03) who were hospitalized due to dengue were more likely to be seropositive for JEV antibodies. However, 244 (91.4%) of adults who were seropositive for JEV had not had the JEV vaccine.

conclusionsDengue seroprevalence rates have risen significantly over the last 12 years in Sri Lanka, possibly due to increased transmission. As individuals who were hospitalized due to dengue were more likely to be seropositive for JEV, the possibility of cross-reactive assays and/or of JEV infection on immunity to the DENV and clinical disease severity should be further investigated.

Indexed as

AdolescentAdultChildCross InfectionCross ReactionsDengueDengue VirusEncephalitis, JapaneseEncephalitis Virus, JapaneseFemaleHospitalizationHumansMaleMiddle AgedSeroepidemiologic StudiesSri Lanka

Identifiers

PMID26696417
PMCPMC4687926
OpenAlexW2239930718

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.